Metrochem API Private Limited Metrochem API Private Limited

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    CAS 281-23-2 manufacturers and suppliers on PharmaCompass

    Client Email Product

    CAS 281-23-2

    Manufacturers/Suppliers

    PharmaCompass
    CAS 281-23-2
    Also known as: 281-23-2, Tricyclo[3.3.1.13,7]decane, Adamantan, Tricyclo[3.3.1.1(3,7)]decane, Einecs 206-001-4, Tricyclo[3.3.1.1~3,7~]decane
    Molecular Formula
    C10H16
    Molecular Weight
    136.23  g/mol
    InChI Key
    ORILYTVJVMAKLC-UHFFFAOYSA-N
    FDA UNII
    PJY633525U
    A tricyclo bridged hydrocarbon.
    1 2D Structure

    CAS 281-23-2

    2 Identification
    2.1 Computed Descriptors
    2.1.1 IUPAC Name
    adamantane
    2.1.2 InChI
    InChI=1S/C10H16/c1-7-2-9-4-8(1)5-10(3-7)6-9/h7-10H,1-6H2
    2.1.3 InChI Key
    ORILYTVJVMAKLC-UHFFFAOYSA-N
    2.1.4 Canonical SMILES
    C1C2CC3CC1CC(C2)C3
    2.2 Other Identifiers
    2.2.1 UNII
    PJY633525U
    2.3 Synonyms
    2.3.1 MeSH Synonyms

    1. Diamantane

    2.3.2 Depositor-Supplied Synonyms

    1. 281-23-2

    2. Tricyclo[3.3.1.13,7]decane

    3. Adamantan

    4. Tricyclo[3.3.1.1(3,7)]decane

    5. Einecs 206-001-4

    6. Tricyclo[3.3.1.1~3,7~]decane

    7. Nsc 527913

    8. Unii-pjy633525u

    9. Chebi:40519

    10. Tricyclo(3.3.1.13,7)decane

    11. Pjy633525u

    12. Nsc-527913

    13. A 0696; Nsc 527913

    14. Ec 206-001-4

    15. Tricyclo[3.3.1.1]decane

    16. Adamantine

    17. Mfcd00074719

    18. Adamantane; >99%

    19. Diamantane (obsolete)

    20. Adamantane, >=99%

    21. Adamantane [mi]

    22. Amy793

    23. Chembl1230831

    24. Dtxsid5022017

    25. Hy-n2427

    26. Adamantane (purified By Sublimation)

    27. C12cc3cc(c1)cc(c2)c3

    28. Nsc527913

    29. Tricyclo[3.3.1.1<3,7>]decane

    30. Adamantane Tricyclo[3.3.1.1]decane

    31. Akos000119960

    32. Akos004908007

    33. Tricyclo(3.3.1.1(3,7)-)decane

    34. Db03627

    35. Ds-4960

    36. Tricyclo(3,3,1,1,<3,7>)-decane

    37. As-12242

    38. Ls-157064

    39. A0696

    40. A3233

    41. Cs-0022641

    42. Ft-0621893

    43. S2869

    44. En300-19684

    45. D88553

    46. A819332

    47. Q351461

    48. W-107075

    49. F0001-0891

    50. Z104474730

    2.4 Create Date
    2004-09-16
    3 Chemical and Physical Properties
    Molecular Weight 136.23 g/mol
    Molecular Formula C10H16
    XLogP33.8
    Hydrogen Bond Donor Count0
    Hydrogen Bond Acceptor Count0
    Rotatable Bond Count0
    Exact Mass g/mol
    Monoisotopic Mass g/mol
    Topological Polar Surface Area0
    Heavy Atom Count10
    Formal Charge0
    Complexity75.1
    Isotope Atom Count0
    Defined Atom Stereocenter Count0
    Undefined Atom Stereocenter Count0
    Defined Bond Stereocenter Count0
    Undefined Bond Stereocenter Count0
    Covalently Bonded Unit Count1
    ListList of Suppliers
    Full View ScreenFull Screen View
    refresh Reset Filter
    refresh Reset Filter
    price-trend Ask Us

    Cangzhou Senary Chemical Science-te...

    Contact Supplier
      Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
      Post an Enquiry Post an Enquiry
      Flag China
      Virtual Booth Virtual Booth
      Digital Content Digital Content

      1,3-dimethyl adamantane

      PDF Supplier PDF
      URL Supplier Web Content
      702-79-4
      Memantine Hydrochloride
      Founded in 2003, Senary Chem is one of the Key High-Tech Enterprises of National Torch Plan. Senary locat...
      Founded in 2003, Senary Chem is one of the Key High-Tech Enterprises of National Torch Plan. Senary located in National Cangzhou Lingang Economic and Technological Development Zone,Cangzhou City,Hebei Province. Senary cover an area of 67,000 square meters, and 300 professionals work there. Senary R&D organization recognized as the Hebei Provincial Engineering Technology Center is comprised of two R & D centers in Tianjin and Cangzhou, and it employs 80 experienced scientists in total. Senary focus on the development, production and sales of advanced pharmaceutical intermediates. Especially, Senary has leading technology and manufacturing capacity for diabetes drug intermediates. All intermediates of DPP4 and SGLT2 class drugs on market have been commercialized production. Senary has 150 sets of 50 ~ 8000L reactor with annual production capacity of 1,000 tons, which can handle both low and high temperature reactions within -100 ~ 240 ℃ range, all kinds of catalytic reactions within 0 ~ 5MPa pressure, and moisture and/or oxygen sensitive reactions. Senary also has expertise in chiral synthesis with leading technologies. The advanced sewage treatment system at Senery has processing capacity of 600 tons daily. Senary has an excellent team that has rich quality management experience.We have established a set of normative and perfect quality managment system,monitoring the whole process of risk assessment,R&D,transfer from pilot scale to commercial production,manufacturing,analysis and sales service. Senary will continue to dedicate on the field of pharmaceutical intermediates to provide the best service for domestic and foreign API pharmaceutical companies with high quality and timely supply of products.
      ASK
      US
      PHARMACOMPASS
      Upload
      your Marketing & Sales content

      Cangzhou Senary Chemical Science-te...

      Contact Supplier
        Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
        Post an Enquiry Post an Enquiry
        Flag China
        Virtual Booth Virtual Booth
        Digital Content Digital Content

        1-Bromo-3,5-dimethyladamantane

        PDF Supplier PDF
        URL Supplier Web Content
        941-37-7
        Memantine Hydrochloride
        Founded in 2003, Senary Chem is one of the Key High-Tech Enterprises of National Torch Plan. Senary locat...
        Founded in 2003, Senary Chem is one of the Key High-Tech Enterprises of National Torch Plan. Senary located in National Cangzhou Lingang Economic and Technological Development Zone,Cangzhou City,Hebei Province. Senary cover an area of 67,000 square meters, and 300 professionals work there. Senary R&D organization recognized as the Hebei Provincial Engineering Technology Center is comprised of two R & D centers in Tianjin and Cangzhou, and it employs 80 experienced scientists in total. Senary focus on the development, production and sales of advanced pharmaceutical intermediates. Especially, Senary has leading technology and manufacturing capacity for diabetes drug intermediates. All intermediates of DPP4 and SGLT2 class drugs on market have been commercialized production. Senary has 150 sets of 50 ~ 8000L reactor with annual production capacity of 1,000 tons, which can handle both low and high temperature reactions within -100 ~ 240 ℃ range, all kinds of catalytic reactions within 0 ~ 5MPa pressure, and moisture and/or oxygen sensitive reactions. Senary also has expertise in chiral synthesis with leading technologies. The advanced sewage treatment system at Senery has processing capacity of 600 tons daily. Senary has an excellent team that has rich quality management experience.We have established a set of normative and perfect quality managment system,monitoring the whole process of risk assessment,R&D,transfer from pilot scale to commercial production,manufacturing,analysis and sales service. Senary will continue to dedicate on the field of pharmaceutical intermediates to provide the best service for domestic and foreign API pharmaceutical companies with high quality and timely supply of products.
        ASK
        US
        PHARMACOMPASS
        Upload
        your Marketing & Sales content
        Ask Us for Pharmaceutical Supplier and Partner
        Ask Us, Find A Supplier / Partner
        No Commissions, No Strings Attached, Get Connected for FREE

        What are you looking for?

        How can we help you?

        The request can't be empty

        Please read our Privacy Policy carefully

        You must agree to the privacy policy

        The name can't be empty
        The company can't be empty.
        The email can't be empty Please enter a valid email.
        The mobile can't be empty
        egis-pharmaceuticals-plc-m-2024-06-10

        Access Virtual Booth

        Contact Supplier

        View Presentation

        Veranova: A CDMO that manages complexity with confidence.

        Access Virtual Booth

        Contact Supplier

        View Presentation

        Post Enquiry
        POST ENQUIRY

        Market Place

        Market Place

        PharmaCompass

        Home

        Market Place

        Menu

        Post Enquiry

        Post Enquiry

        Market Place

        Market Place

        Search